Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infected”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00058734
What this trial is testing

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 5
Post-approval studies (Phase 4)Study completedNCT02724852
What this trial is testing

MMR Vaccination Among HIV-infected Adults

Who this might be right for
HIV
Chiang Mai University 632
Post-approval studies (Phase 4)Study completedNCT00718536
What this trial is testing

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01092104
What this trial is testing

A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 52
Not applicableUnknownNCT01162538
What this trial is testing

To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients

Who this might be right for
EvaluatedNon B SubtypeNaive Patients
Centre Hospitalier Intercommunal Robert Ballanger 60
Not applicableStudy completedNCT00002307
What this trial is testing

A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT01025830
What this trial is testing

Triomune Bioequivalence With Innovators

Who this might be right for
HIV/AIDS
Makerere University 20
Early research (Phase 1)Study completedNCT00712530
What this trial is testing

Single DermaVir Immunization in HIV-1 Infected Patients on HAART

Who this might be right for
HIV Infection
Genetic Immunity 9
Not applicableStudy completedNCT02301507
What this trial is testing

Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women

Who this might be right for
HIV Infection
The University of Texas Health Science Center, Houston 7
Large-scale testing (Phase 3)Study completedNCT03311945
What this trial is testing

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM

Who this might be right for
HIV InfectionsHIV-1-infectionHIV Seropositivity
Judit Pich 33
Early research (Phase 1)Study completedNCT00000865
What this trial is testing

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Large-scale testing (Phase 3)Study completedNCT02103439
What this trial is testing

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Who this might be right for
HepatitisHepatitis CHepatitis C/ Human Immunodeficiency Virus Coinfection
Biocad 140
Testing effectiveness (Phase 2)Study completedNCT03435146
What this trial is testing

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

Who this might be right for
Respiratory Tract InfectionsHIV Infections
The Aurum Institute NPC 135
Early research (Phase 1)Study completedNCT00000761
What this trial is testing

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT02191202
What this trial is testing

Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression

Who this might be right for
HIV Infections
Boehringer Ingelheim 283
Not applicableStudy completedNCT00002172
What this trial is testing

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

Who this might be right for
HIV Infections
The Immune Response Corporation
Large-scale testing (Phase 3)Study completedNCT01667731
What this trial is testing

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 224
Not applicableEnded earlyNCT01040039
What this trial is testing

Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV

Who this might be right for
HIV InfectionsHepatitis C Virus
Rockefeller University 20
Very early researchStudy completedNCT00719602
What this trial is testing

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

Who this might be right for
HIV InfectionsMalaria
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 105
Next Page